Hepatic Epithelioid Hemangioendothelioma Successfully Treated with Living Donor Liver Transplantation: A Case Report and Literature Review
Overview
Authors
Affiliations
Hepatic epithelioid hemangioendothelioma is a rare neoplasm with a variable malignant potential and a high risk of recurrence. No general treatment guidelines have been established. Fortunately, we were able to minimize immunosuppressant after liver transplantation because of a full HLA-matched case. There was no recurrence 1 year after treatment.
Primary hepatic epithelioid hemangioendothelioma: a case report.
Wang J, Yang Q, Lu B, Cai Y, Yin J J Int Med Res. 2024; 52(12):3000605241306649.
PMID: 39731438 PMC: 11686786. DOI: 10.1177/03000605241306649.
Wang B, Chen X, Li R, Ai B, Ye F, Zhao J Front Immunol. 2024; 15:1491922.
PMID: 39502705 PMC: 11534872. DOI: 10.3389/fimmu.2024.1491922.
Narayanan G, Spano A, Gentile N, Shnayder-Adams M, Gurusamy V, Levi D Cardiovasc Intervent Radiol. 2024; 47(7):883-890.
PMID: 38844684 PMC: 11239779. DOI: 10.1007/s00270-024-03770-5.
Hepatic epithelioid hemangioendothelioma-a single-institution experience with 51 cases.
Feng L, Li M, Huang Z, Xu M Front Oncol. 2023; 13:1236134.
PMID: 37601682 PMC: 10435877. DOI: 10.3389/fonc.2023.1236134.
Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy.
Kou K, Chen Y, Zhou J, Sun X, Sun D, Li S World J Clin Cases. 2020; 8(18):3978-3987.
PMID: 33024754 PMC: 7520791. DOI: 10.12998/wjcc.v8.i18.3978.